ASM Meeting Draws 12,000 To Miami Beach

WASHINGTON--Between 12,000 and 14,000 scientists are expected to attend the 88th annual meeting of the American Society for Microbiology (ASM) in Miami Beach next week. The six-day meeting, which begins Sunday, May 8, will feature 315 sessions (including poster sessions), exhibits by more than 300 companies, a placement service and a special student science day. Also, ASM’s Committee on Continuing Education of the Board of Education and Training is sponsponsoring 24 advance workshops for

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The six-day meeting, which begins Sunday, May 8, will feature 315 sessions (including poster sessions), exhibits by more than 300 companies, a placement service and a special student science day. Also, ASM’s Committee on Continuing Education of the Board of Education and Training is sponsponsoring 24 advance workshops for microbiologists, technologists, clinicians, public health officers, veterinarians, managers, directors and researchers.

One highlight will be a Monday morning symposium on AIDS. Speakers at the session, in the Fontainbleau Hotel, will include James W. Curran of the Centers for Disease Control, William A. Blattner of the National Cancer Institute, Myron Essex of Harvard University, Dani P. Bolognesi of the Duke University Medical Center and Nobel Laureate David Bal- timore of the Whitehead Institute.

Other prominent activities include the presidential address by Barbara Iglewski of the University of Rochester Medical Center, the Eli Lilly Award address for microiology and immunology by Elizabeth Blackburn ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies